N/A N=178 Audiovisual Interactive Games to Alleviate Pediatric Perioperative Anxiety
Anxiety
Primary: Patient Anxiety Assessed by Modified Yale Perioperative Anxiety Score (mYPAS) — 5; 21.4; 0.18; 8.9 score on a scale — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=544 NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems
Pain, Chronic
Primary: Pain Responder Rate — 158; 49; 21 Participants
Phase 4 N=72 Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide
Pregnancy · Cesarean Section · Aspiration
Primary: Change in Gastric Volume (mL) — -1; -2; 0; 1 Milliliters — p=.001
N/A N=25 Clinical Study of Released Unitron RIC and BTE Hearing Aid Models
Hearing Loss
Primary: Speech Intelligibility Test in Noise — 0.83; -2.49; -2.74 decibel (dB) Signal-to-Noise Ratio — p=0.0001
N/A N=28 Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
Neuropathy;Peripheral · Chemotherapy-induced Peripheral Neuropathy · Neuropathy
Primary: Change in Subjective Measurement of Chemotherapy-induced Peripheral Neuropathy — 27.32; 27.94 score on a scale
N/A N=50 Effects of Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With Lateral Epicondylitis
Lateral Epicondylitis
Primary: Degree of Pain Rating (VAS) — 36.92; 51.40 units on a scale
Phase 3 N=62 A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)
Generalized Myasthenia Gravis
Primary: Percentage of Participants With Successful Self-administration of Rozanolixizumab (With Correct Use of Syringe Driver and Manual Push, Respectively) During the…
Phase 2 N=24 Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis
Multiple Sclerosis
Primary: Change From Baseline in Physical Health Composite Score - Multiple Sclerosis Quality of Life (MSQOL) 54 Instrument — 53.85; 44.07; 8.21; 7.03 score on a scale (100…
Phase 1 N=76 Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.
Healthy Volunteer Study
Primary: Change From Baseline in Observer's Assessment of Alertness/Sedation Scale (OAAS/S) (Part A) — 0; 0; 0; 0 score on a scale (change)
Phase 3 N=285 Comparing TAP Blocks Bupivacaine, and Placebo for Plane
Abdominal Surgery
Primary: Total Opioids During Postoperative 24 Hours — 26; 33; 31 morphine milligram equivalents — p=0.355
N/A N=1,101 Pragmatic RCT of SBIRT-PM
Substance Use Disorders · Pain
Primary: Change in Pain Intensity Subscale of Brief Pain Inventory — 5.39; 5.39; 5.02; 4.97 score on a scale
N/A N=1,073 My Recordable On-Demand Audio Discharge Instructions
Heart Failure, Congestive
Primary: Number of Patients Rehospitalized With Heart Failure — 71; 78; 425; 397 Participants
Phase 4 N=10 A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
Acne Vulgaris
Primary: The Primary Endpoint of This Study is the Percent of Patients Who Achieved Clear (0) or Almost Clear (1) on IGA Scale at Week 16 — 78 percentage of participants — p=<0.008
N/A N=15 Gingival Crevicular Fluid Characterization During Orthodontic Treatment
Healthy · Maxillary First Premolar Tooth Extraction · Canine Retraction
Primary: The Distance of Tooth Movement — 5 millimeters
Phase 1 N=75 Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects
GERD
Primary: AUC0-24h Linaprazan (QD) — 5057; 8924; 13900; 4640 nmol/L*h